When MLR-/NLR-/PLR-Low vs MLR-/NLR-/PLR-High groups at baseline (n = 97) were correlated with clinical characteristics (visceral metastasis, negative PR status, prior endocrine therapy, prior chemotherapy, de novo vs recurrent metastatic disease, one or more than one site of metastasis, age at therapy start) in the entire cohort, no significant differences were obtained by two-tailed Fisher’s exact test. Here, PGR is linked to metastatic neoplasm.